Managing the Patient With Multiple Primary Tumors

Multiple primaries are defined as more than one synchronous or metachronous cancer in the same individual. They can pose challenges to clinicians, as the goal is to find an anticancer therapy strategy that covers both cancer types without increased toxicity or drug interactions, and does not negativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chitwood, Holly, Carey, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184849/
https://www.ncbi.nlm.nih.gov/pubmed/37197724
http://dx.doi.org/10.6004/jadpro.2023.14.3.7
_version_ 1785042223257092096
author Chitwood, Holly
Carey, Tamara
author_facet Chitwood, Holly
Carey, Tamara
author_sort Chitwood, Holly
collection PubMed
description Multiple primaries are defined as more than one synchronous or metachronous cancer in the same individual. They can pose challenges to clinicians, as the goal is to find an anticancer therapy strategy that covers both cancer types without increased toxicity or drug interactions, and does not negatively impact a patient's overall outcome. At JADPRO Live 2022, presenters tackled this complicated topic by reviewing diagnostic criteria, epidemiology, and risk factors, demonstrating the prioritization of treatment, and discussing the role of the advanced practitioner in collaborative, interdisciplinary management of the patient with multiple primary tumors.
format Online
Article
Text
id pubmed-10184849
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-101848492023-05-16 Managing the Patient With Multiple Primary Tumors Chitwood, Holly Carey, Tamara J Adv Pract Oncol Meeting Reports Multiple primaries are defined as more than one synchronous or metachronous cancer in the same individual. They can pose challenges to clinicians, as the goal is to find an anticancer therapy strategy that covers both cancer types without increased toxicity or drug interactions, and does not negatively impact a patient's overall outcome. At JADPRO Live 2022, presenters tackled this complicated topic by reviewing diagnostic criteria, epidemiology, and risk factors, demonstrating the prioritization of treatment, and discussing the role of the advanced practitioner in collaborative, interdisciplinary management of the patient with multiple primary tumors. Harborside Press LLC 2023-04 2023-04-01 /pmc/articles/PMC10184849/ /pubmed/37197724 http://dx.doi.org/10.6004/jadpro.2023.14.3.7 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Chitwood, Holly
Carey, Tamara
Managing the Patient With Multiple Primary Tumors
title Managing the Patient With Multiple Primary Tumors
title_full Managing the Patient With Multiple Primary Tumors
title_fullStr Managing the Patient With Multiple Primary Tumors
title_full_unstemmed Managing the Patient With Multiple Primary Tumors
title_short Managing the Patient With Multiple Primary Tumors
title_sort managing the patient with multiple primary tumors
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184849/
https://www.ncbi.nlm.nih.gov/pubmed/37197724
http://dx.doi.org/10.6004/jadpro.2023.14.3.7
work_keys_str_mv AT chitwoodholly managingthepatientwithmultipleprimarytumors
AT careytamara managingthepatientwithmultipleprimarytumors

Ejemplares similares